Literature DB >> 24584350

The importance of harmonizing interim positron emission tomography in non-Hodgkin lymphoma: focus on the Deauville criteria.

Elske Quak1, Narinée Hovhannisyan2, Charline Lasnon3, Christophe Fruchart4, Jean-Pierre Vilque4, Dada Musafiri4, Nicolas Aide3.   

Abstract

Entities:  

Keywords:  Deauville criteria; FDG-PET/CT; PSF reconstruction; SUV; interim PET; non-Hodgkin lymphoma

Mesh：

Year:  2014        PMID： 24584350      PMCID： PMC4040900          DOI： 10.3324/haematol.2014.104125

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  11 in total

1.  Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0.

Authors:  Dominique Delbeke; R Edward Coleman; Milton J Guiberteau; Manuel L Brown; Henry D Royal; Barry A Siegel; David W Townsend; Lincoln L Berland; J Anthony Parker; Karl Hubner; Michael G Stabin; George Zubal; Marc Kachelriess; Valerie Cronin; Scott Holbrook
Journal:  J Nucl Med       Date:  2006-05       Impact factor: 10.057

2.  Impact of point spread function reconstruction on thoracic lymph node staging with 18F-FDG PET/CT in non-small cell lung cancer.

Authors:  Charline Lasnon; Rodney J Hicks; Jean-Mathieu Beauregard; Alvin Milner; Maria Paciencia; Anne-Valérie Guizard; Stéphane Bardet; Radj Gervais; Gabriel Lemoel; Gérard Zalcman; Nicolas Aide
Journal:  Clin Nucl Med       Date:  2012-10       Impact factor: 7.794

3.  Clinical evaluation of PET image reconstruction using a spatial resolution model.

Authors:  Flemming Littrup Andersen; Thomas Levin Klausen; Annika Loft; Thomas Beyer; Søren Holm
Journal:  Eur J Radiol       Date:  2012-12-17       Impact factor: 3.528

4.  Report on the Third International Workshop on Interim Positron Emission Tomography in Lymphoma held in Menton, France, 26-27 September 2011 and Menton 2011 consensus.

Authors:  Michel Meignan; Andrea Gallamini; Emmanuel Itti; Sally Barrington; Corinne Haioun; Aaron Polliack
Journal:  Leuk Lymphoma       Date:  2012-04-23

5.  Report on the 4th International Workshop on Positron Emission Tomography in Lymphoma held in Menton, France, 3-5 October 2012.

Authors:  Michel Meignan; Sally Barrington; Emmanuel Itti; Andrea Gallamini; Corinne Haioun; Aaron Polliack
Journal:  Leuk Lymphoma       Date:  2013-06-14

6.  Harmonizing SUVs in multicentre trials when using different generation PET systems: prospective validation in non-small cell lung cancer patients.

Authors:  Charline Lasnon; Cédric Desmonts; Elske Quak; Radj Gervais; Pascal Do; Catherine Dubos-Arvis; Nicolas Aide
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-04-06       Impact factor: 9.236

7.  Influences of point-spread function and time-of-flight reconstructions on standardized uptake value of lymph node metastases in FDG-PET.

Authors:  Go Akamatsu; Katsuhiko Mitsumoto; Takafumi Taniguchi; Yuji Tsutsui; Shingo Baba; Masayuki Sasaki
Journal:  Eur J Radiol       Date:  2013-10-06       Impact factor: 3.528

8.  Evaluation of strategies towards harmonization of FDG PET/CT studies in multicentre trials: comparison of scanner validation phantoms and data analysis procedures.

Authors:  Nikolaos E Makris; Marc C Huisman; Paul E Kinahan; Adriaan A Lammertsma; Ronald Boellaard
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-06-11       Impact factor: 9.236

9.  FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0.

Authors:  Ronald Boellaard; Mike J O'Doherty; Wolfgang A Weber; Felix M Mottaghy; Markus N Lonsdale; Sigrid G Stroobants; Wim J G Oyen; Joerg Kotzerke; Otto S Hoekstra; Jan Pruim; Paul K Marsden; Klaus Tatsch; Corneline J Hoekstra; Eric P Visser; Bertjan Arends; Fred J Verzijlbergen; Josee M Zijlstra; Emile F I Comans; Adriaan A Lammertsma; Anne M Paans; Antoon T Willemsen; Thomas Beyer; Andreas Bockisch; Cornelia Schaefer-Prokop; Dominique Delbeke; Richard P Baum; Arturo Chiti; Bernd J Krause
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-01       Impact factor: 9.236

10.  SUVref: reducing reconstruction-dependent variation in PET SUV.

Authors:  Matthew D Kelly; Jerome M Declerck
Journal:  EJNMMI Res       Date:  2011-08-18       Impact factor: 3.138
View more
  5 in total

Review 1.  FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas.

Authors:  Sally F Barrington; Regine Kluge
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-04-14       Impact factor: 9.236

Review 2.  EANM/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies.

Authors:  Nicolas Aide; Charline Lasnon; Patrick Veit-Haibach; Terez Sera; Bernhard Sattler; Ronald Boellaard
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-06-16       Impact factor: 9.236

3.  Comparison of therapeutic evaluation criteria in FDG-PET/CT in patients with diffuse large-cell B-cell lymphoma: Prognostic impact of tumor/liver ratio.

Authors:  Mathieu N Toledano; Pierre Vera; Hervé Tilly; Fabrice Jardin; Stéphanie Becker
Journal:  PLoS One       Date:  2019-02-07       Impact factor: 3.240

4.  Harmonizing FDG PET quantification while maintaining optimal lesion detection: prospective multicentre validation in 517 oncology patients.

Authors:  Elske Quak; Pierre-Yves Le Roux; Michael S Hofman; Philippe Robin; David Bourhis; Jason Callahan; David Binns; Cédric Desmonts; Pierre-Yves Salaun; Rodney J Hicks; Nicolas Aide
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-07-30       Impact factor: 9.236

5.  EORTC PET response criteria are more influenced by reconstruction inconsistencies than PERCIST but both benefit from the EARL harmonization program.

Authors:  Charline Lasnon; Elske Quak; Pierre-Yves Le Roux; Philippe Robin; Michael S Hofman; David Bourhis; Jason Callahan; David S Binns; Cédric Desmonts; Pierre-Yves Salaun; Rodney J Hicks; Nicolas Aide
Journal:  EJNMMI Phys       Date:  2017-05-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.